Nothing Special   »   [go: up one dir, main page]

GB9807931D0 - Improvements in or relating to protease inhibitors - Google Patents

Improvements in or relating to protease inhibitors

Info

Publication number
GB9807931D0
GB9807931D0 GBGB9807931.2A GB9807931A GB9807931D0 GB 9807931 D0 GB9807931 D0 GB 9807931D0 GB 9807931 A GB9807931 A GB 9807931A GB 9807931 D0 GB9807931 D0 GB 9807931D0
Authority
GB
United Kingdom
Prior art keywords
relating
protease inhibitors
protease
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9807931.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB9807931.2A priority Critical patent/GB9807931D0/en
Publication of GB9807931D0 publication Critical patent/GB9807931D0/en
Priority to PCT/GB1999/001129 priority patent/WO1999052516A2/en
Priority to AU34352/99A priority patent/AU3435299A/en
Priority to EP99915931A priority patent/EP1077689A1/en
Priority to JP2000543126A priority patent/JP2002511407A/en
Priority to CA002328360A priority patent/CA2328360A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9807931.2A 1998-04-15 1998-04-15 Improvements in or relating to protease inhibitors Ceased GB9807931D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9807931.2A GB9807931D0 (en) 1998-04-15 1998-04-15 Improvements in or relating to protease inhibitors
PCT/GB1999/001129 WO1999052516A2 (en) 1998-04-15 1999-04-14 Acylpeptide protease inhibitors to enhance cognitive function
AU34352/99A AU3435299A (en) 1998-04-15 1999-04-14 Improvements in or relating to protease inhibitors
EP99915931A EP1077689A1 (en) 1998-04-15 1999-04-14 Acylpeptide protease inhibitors to enhance cognitive function
JP2000543126A JP2002511407A (en) 1998-04-15 1999-04-14 Improvements in or related to protease inhibitors
CA002328360A CA2328360A1 (en) 1998-04-15 1999-04-14 Improvements in or relating to protease inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9807931.2A GB9807931D0 (en) 1998-04-15 1998-04-15 Improvements in or relating to protease inhibitors

Publications (1)

Publication Number Publication Date
GB9807931D0 true GB9807931D0 (en) 1998-06-10

Family

ID=10830327

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9807931.2A Ceased GB9807931D0 (en) 1998-04-15 1998-04-15 Improvements in or relating to protease inhibitors

Country Status (6)

Country Link
EP (1) EP1077689A1 (en)
JP (1) JP2002511407A (en)
AU (1) AU3435299A (en)
CA (1) CA2328360A1 (en)
GB (1) GB9807931D0 (en)
WO (1) WO1999052516A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008055249A2 (en) * 2006-10-31 2008-05-08 Mgp Biotechnologies, Inc. Butyrylcholinesterase inhibitors and their use in the treatment of neurodegenerative diseases
US9757399B2 (en) 2006-10-31 2017-09-12 Jal Therapeutics, Inc. Butyrylcholinesterase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4217396A1 (en) * 1992-05-26 1993-12-02 Bayer Ag Metrifonate-containing drug
WO1998030243A1 (en) * 1997-01-08 1998-07-16 Warner-Lambert Company Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease

Also Published As

Publication number Publication date
EP1077689A1 (en) 2001-02-28
CA2328360A1 (en) 1999-10-21
JP2002511407A (en) 2002-04-16
WO1999052516A2 (en) 1999-10-21
AU3435299A (en) 1999-11-01
WO1999052516A3 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
PL349192A1 (en) Protease inhibitors
HUP0102878A3 (en) Improvements in or relating to contrast agents
GB9927043D0 (en) Improvements in or relating to sealing arrangements
EP1093367A4 (en) Protease inhibitors
GB9916628D0 (en) Improvements in or relating to karabiners
EP1067894A4 (en) Protease inhibitors
GB0017507D0 (en) Improvemnts in or relating to watermarks
EP1079821A4 (en) Protease inhibitors
GB2343935B (en) Improvements in or relating to valves
GB2345154B (en) Improvements in or relating to positioning
EP1086083A4 (en) Protease inhibitors
EP1140897A4 (en) Protease inhibitors
GB2336885B (en) Improvements in or relating to pipes
GB9919046D0 (en) Improvements in or relating to pallets
GB9807931D0 (en) Improvements in or relating to protease inhibitors
GB9808581D0 (en) Improvements in or relating to contrast agents
GB2368879B (en) Improvements in or relating to keeps
GB9827570D0 (en) Improvements in or relating to valves
GB2342699B (en) Improvements in or relating to pumps
GB9827308D0 (en) Improvements in or relating to pipes
GB2360994B (en) Improvements in or relating to stairlifts
GB9804467D0 (en) Improvements in or relating to gaskets
GB9908569D0 (en) Improvements in or relating to stairlifts
GB9822812D0 (en) Improvements in or relating to stairlifts
GB9822802D0 (en) Improvements in or relating to stairlifts

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)